FLT3 inhibition in acute myeloid leukaemia
Lancet Oncol
.
2017 Aug;18(8):988-989.
doi: 10.1016/S1470-2045(17)30509-0.
Epub 2017 Jul 26.
Authors
Naval Daver
1
,
Hagop Kantarjian
2
Affiliations
1
Department of Leukemia, MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: ndaver@mdanderson.org.
2
Department of Leukemia, MD Anderson Cancer Center, Houston, TX 77030, USA.
PMID:
28759368
DOI:
10.1016/S1470-2045(17)30509-0
No abstract available
Publication types
Comment
MeSH terms
Humans
Leukemia, Myeloid, Acute*
Mutation
fms-Like Tyrosine Kinase 3 / genetics*
Substances
FLT3 protein, human
fms-Like Tyrosine Kinase 3
Grants and funding
P30 CA016672/CA/NCI NIH HHS/United States